DL-Laudanosine
DL-Laudanosine is a known metabolite formed from the neuromuscular blocking agents atracurium and cisatracurium. It is utilized in pharmacological research to study its potential central nervous system effects and pharmacokinetics in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1699-51-0
Product Name Alternative
DLLaudanosine, DL-Laudanosine, DL Laudanosine, DrugMetabolite, Drug Metabolite
Field of Research
Metabolism Research
Purity
98.45% (May vary between batches)
Solubility
DMSO:11 mg/mL (30.77 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.6 mM)
Smiles
COc1ccc (CC2N (C) CCc3cc (OC) c (OC) cc23) cc1OC
Molecular Formula
C21H27NO4
Molecular Weight
357.44
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1209014-01 0.02 mg (E-Coli)
Recombinant Staphylococcus aureus Putative membrane protein insertion efficiency factor (MW1733)
Sign In for Pricing
View Details MBS1209014-02 0.1 mg (E-Coli)
Recombinant Staphylococcus aureus Putative membrane protein insertion efficiency factor (MW1733)
Sign In for Pricing
View Details MBS1209014-03 0.02 mg (Yeast)
Recombinant Staphylococcus aureus Putative membrane protein insertion efficiency factor (MW1733)
Sign In for Pricing
View Details MBS1209014-04 0.1 mg (Yeast)
Recombinant Staphylococcus aureus Putative membrane protein insertion efficiency factor (MW1733)
Sign In for Pricing
View Details MBS1209014-05 0.02 mg (Baculovirus)
Recombinant Staphylococcus aureus Putative membrane protein insertion efficiency factor (MW1733)
Sign In for Pricing
View Details MBS1209014-06 1 mg (E-Coli)
Recombinant Staphylococcus aureus Putative membrane protein insertion efficiency factor (MW1733)
Sign In for Pricing
View Details